PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, San Cecilio University Hospital, Hospital Universitario San Cecilio, Avda. del Conocimiento s/n, 18016, Granada, Spain. iaomarmillan@hotmail.com.\', \'Department of Rheumatology, San Cecilio University Hospital, Granada, Spain.\', \'Department of Statistics and Operational Research, University of Granada, Granada, Spain.\', \'Department of Infectious Diseases, San Cecilio University Hospital, Granada, Spain.\', \'Department of Internal Medicine, San Cecilio University Hospital, Hospital Universitario San Cecilio, Avda. del Conocimiento s/n, 18016, Granada, Spain.\', \'Department of Intensive Care Unit, San Cecilio University Hospital, Granada, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11739-020-02600-z
?:doi
?:hasPublicationType
?:journal
  • Internal and emergency medicine
is ?:pmid of
?:pmid
?:pmid
  • 33400157
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.735
?:rankingScore_hIndex
  • 36
is ?:relation_isRelatedTo_publication of
?:title
  • Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all